Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-09-16

Clinical Trial Update: Study of Induction Therapy With Mitoxantrone and Plasmapheresis to Treat Aggressive Multiple Sclerosis [NA]

View source ↗

Summary

Clinical trial update on induction therapy using mitoxantrone and plasmapheresis for aggressive multiple sclerosis has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mitoxantrone (mitoxantrone)
  • plasmapheresis

Snippet

Sponsor: Isfahan University of Medical Sciences | Conditions: Multiple Sclerosis | NA | Status: COMPLETED | Results posted: 2020-09-16